Last reviewed · How we verify
NCT07325877: SupraBilS
Supra-papillary Versus Trans-papillary Biliary Stenting in Malignant Peri-hilar Stenosis
NA trial testing ERCP with suprapapillary stent placement in Biliary Disease Tract in 70 participants. Not yet recruiting.
1 March 2029
Quick facts
| Lead sponsor | Azienda Ospedaliera Universitaria Integrata Verona |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 March 2026 |
| Primary completion | 1 March 2029 |
| Estimated completion | 1 March 2029 |
Drugs / interventions tested
- ERCP with suprapapillary stent placement
- ERCP with transpapillary stent placement
Conditions studied
- Biliary Disease Tract — all drugs for Biliary Disease Tract →
- Biliary Stenosis — all drugs for Biliary Stenosis →
- Biliary Stents — all drugs for Biliary Stents →
Sponsor
Azienda Ospedaliera Universitaria Integrata Verona — full company profile →
Who can join
18 and older, any sex, with Biliary Disease Tract or Biliary Stenosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized controlled trial comparing patients with obstructive jaundice due to malignancies of the perihilar area of bile ducts and undergoing both preoperative and palliative biliary drainage. The comparison will focus on the technique:, on the one hand, an arm of patients undergoing standard-of-care ERCP with trans-papillary plastic protesis placement, and on the other hand, an experimental arm of patients undergoing suprapapillary plastic protesis placement with no sphincterotomy. The primary objective will be to compare the time-to-stent dysfunction in the two groups; secondary objectives will include a comparison of the safety, technical, and clinical success of the procedures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07325877
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Biliary Disease Tract
Currently open trials in the same condition.
- NCT06026449 — Gluten-free Diet in PSC and IBD · NA · active not recruiting
Other Azienda Ospedaliera Universitaria Integrata Verona trials
Trials by the same sponsor.
- NCT07289035 — Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators. · Phase 2 · not yet recruiting
- NCT07186582 — Verona Coronary Physiology Interventional Registry · active not recruiting
- NCT06820541 — Gallbladder Stenting in FC-SEMS · NA · not yet recruiting
- NCT07338708 — Visual Outcomes and Quality of Life After Vivity EDOF IOL Implantation in Early-Stage Keratoconus · NA · completed
- NCT07207928 — Evaluation of Clinical Outcomes, Tolerability, and Costs of Avelumab Maintenance and Pembrolizumab Second-Line Therapy i · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07325877 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda Ospedaliera Universitaria Integrata Verona
- Last refreshed: 8 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07325877.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing